Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Volitionrx (VNRX) Total Non-Current Liabilities (2019 - 2025)

Volitionrx's Total Non-Current Liabilities history spans 9 years, with the latest figure at $31.0 million for Q3 2025.

  • For Q3 2025, Total Non-Current Liabilities rose 514.48% year-over-year to $31.0 million; the TTM value through Sep 2025 reached $31.0 million, up 514.48%, while the annual FY2024 figure was $27.7 million, 474.36% up from the prior year.
  • Total Non-Current Liabilities reached $31.0 million in Q3 2025 per VNRX's latest filing, down from $32.6 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $32.6 million in Q2 2025 to a low of -$31.4 million in Q1 2021.
  • Average Total Non-Current Liabilities over 5 years is $12.9 million, with a median of $9.5 million recorded in 2021.
  • Peak YoY movement for Total Non-Current Liabilities: tumbled 524.88% in 2021, then soared 552.55% in 2025.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $9.5 million in 2021, then tumbled by 57.58% to $4.0 million in 2022, then increased by 19.57% to $4.8 million in 2023, then surged by 474.36% to $27.7 million in 2024, then grew by 11.76% to $31.0 million in 2025.
  • Per Business Quant, the three most recent readings for VNRX's Total Non-Current Liabilities are $31.0 million (Q3 2025), $32.6 million (Q2 2025), and $29.3 million (Q1 2025).